Literature DB >> 7794524

In vitro amyloid fibril formation from alpha 1-antitrypsin.

S Janciauskiene1, E Carlemalm, S Eriksson.   

Abstract

We have previously shown that the interaction between alpha 1-antitrypsin (AAT) and lithocholic acid (LA) results in changes of AAT properties leading to its polymerization and inactivation. To define the structural rearrangements of AAT induced by such interaction, we studied the in vitro binding between AAT and LA at molar ratio 1:5 for varying time intervals at a physiological pH. Complex formation was shown by electrophoretic techniques and autoradiography. Studies of the AAT in complex with LA by using far-UV spectra circular dichroism and fluorescence measurements indicated an increase of beta-structure of AAT and pronounced changes in surroundings of the chromophores. In addition, complexed AAT showed increase in thermal stability, compatible with that after proteolytic cleavage. Characterization of the AAT-LA complexes by Congo red binding, polarization and negative staining electron microscopy provided clear evidence that AAT, under chosen experimental conditions, can self-assemble into amyloid fibrils, compatible with accepted models of fibrillar structures. This propensity of AAT to form stable beta-structures in a hydrophobic surrounding may contribute to improved characterization of various amyloid deposits occurring in vivo and be a guide for understanding details of structure-function relationships in the intact AAT-molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794524     DOI: 10.1515/bchm3.1995.376.2.103

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  2 in total

1.  Cleaved antitrypsin polymers at atomic resolution.

Authors:  M A Dunstone; W Dai; J C Whisstock; J Rossjohn; R N Pike; S C Feil; B F Le Bonniec; M W Parker; S P Bottomley
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

2.  Effect of beta propiolactone viral inactivation on alpha1 antitrypsin values.

Authors:  S J Katona; M Bowen; E R Kaminski
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.